Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
57.27
Price to sales ratio
1.36

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
993
ALKS
Alkermes plc - Ordinary Shares
51.87 USD-0.13%-6.32%+17.57%+73.25%8.65 B USD
1120
LNTH
Lantheus Holdings, Inc. - Common Stock
105.39 USD-0.24%+3.83%+0.59%+88.00%6.86 B USD
1358
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
40.21 USD-0.72%+0.47%+3.93%+19.67%4.90 B USD
1776
SUPN
Supernus Pharmaceuticals, Inc. - Common Stock
47.35 USD-2.29%-0.80%+6.74%-12.31%2.75 B USD

Frequently asked questions about Amneal Pharmaceuticals, Inc. - Class A Common Stock

What is the Amneal Pharmaceuticals, Inc. - Class A Common Stock stock price today?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock (AMRX) is 17.18. Over the past 24 hours, the stock has changed by +1.00%. Follow the AMRX chart for real-time price dynamics.

What is the stock ticker of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades under the ticker AMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock stock going up?

AMRX has changed by +0.29% over the last week, +6.58% over the last month, and +62.84% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Amneal Pharmaceuticals, Inc. - Class A Common Stock net income for the last quarter?

Amneal Pharmaceuticals, Inc. - Class A Common Stock reported net income of 62.26 M for the last quarter. The previous quarter showed 35.08 M, which means net income changed by +77.49%.

How many employees does Amneal Pharmaceuticals, Inc. - Class A Common Stock have?

As of the latest available data, Amneal Pharmaceuticals, Inc. - Class A Common Stock has 8 500 employees. Workforce size can provide additional context about the company's scale and operations.

What is Amneal Pharmaceuticals, Inc. - Class A Common Stock EBITDA?

Amneal Pharmaceuticals, Inc. - Class A Common Stock EBITDA is 140.26 M, and its EBITDA margin is 19.41%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Amneal Pharmaceuticals, Inc. - Class A Common Stock stock?

You can buy Amneal Pharmaceuticals, Inc. - Class A Common Stock (AMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Amneal Pharmaceuticals, Inc. - Class A Common Stock stock?

Investing in Amneal Pharmaceuticals, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AMRX chart and related analysis on metatrader.com as part of your research.

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

News